Home / Ingredients / Probiotics
Evidence reviewed: 2026-10-02
Evidence is strain- and indication-specific; generic probiotic claims are not scientifically interchangeable.
NIH ODS emphasizes that probiotic effects can be strain-specific. Some GI endpoints show modest benefits for particular strains or combinations, while other conditions have uncertain or negative evidence.
Species name alone is often insufficient; strain, dose, duration, population, and outcome matter.
Usually minor adverse effects in healthy people, but serious infections have been reported in severely ill or immunocompromised people. Special caution is warranted in high-risk populations.
SMARTBIOTICS KIDS lists named strains, which is more useful than a generic 'probiotic blend,' but product efficacy still requires matching those exact strains and doses to human studies. Other products list probiotics without full dose/CFU information.
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis (Systematic review and meta-analysis; PMID 29868585)
Population/scope: 228 controlled trials across multiple probiotic strains and indications
Evidence scope: Strain-specific and disease-specific probiotic efficacy
Finding: Efficacy differed materially by strain and disease indication; pooling different probiotics can produce misleading generalizations.
Limitations: Findings cannot be transferred from one strain, mixture, dose, population, or indication to another.
Directness: Relevant human evidence · verified 2026-10-02
Important: Ingredient-level evidence is not proof that a finished product has the same effect. Dose, form, population, duration, and formulation must match.
For informational purposes only; not individualized medical advice.